Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease.
about
Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study.Low Serum IgE Is a Sensitive and Specific Marker for Common Variable Immunodeficiency (CVID).The Fab fragment of anti-IgE Cε2 domain prevents allergic reactions through interacting with IgE-FcεRIα complex on rat mast cells
P2860
Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Half-life of IgE in serum and ...... atients with allergic disease.
@ast
Half-life of IgE in serum and ...... atients with allergic disease.
@en
type
label
Half-life of IgE in serum and ...... atients with allergic disease.
@ast
Half-life of IgE in serum and ...... atients with allergic disease.
@en
prefLabel
Half-life of IgE in serum and ...... atients with allergic disease.
@ast
Half-life of IgE in serum and ...... atients with allergic disease.
@en
P2093
P2860
P1476
Half-life of IgE in serum and ...... atients with allergic disease.
@en
P2093
Alexander J Schuyler
Leland C Stillman
Martin D Chapman
Monica G Lawrence
P2860
P304
422-428.e4
P356
10.1016/J.JACI.2016.04.056
P407
P577
2016-07-14T00:00:00Z